New Issue: HemoSense wraps $7 million stock offering

By Sheri Kasprzak

New York, Dec. 12 - HemoSense, Inc. completed a private placement of stock for $6,991,500.

The company sold 1.77 million shares at $3.95 each to New Enterprise Associates.

Proceeds will be used for business development.

San Jose, Calif.-based HemoSense develops handheld blood coagulation systems for monitoring patients using warfarin for blood clotting.

Issuer:	HemoSense, Inc.
Issue:	Stock
Amount:	$6,991,500
Shares:	1.77 million
Price:	$3.95
Warrants:	No
Investor:	New Enterprise Associates
Settlement date:	Dec. 12
Stock symbol:	Amex: HEM
Stock price:	$4.07 at close Dec. 12

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.